Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:309136
Who is this for?
Show terms as
3Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes is a group of rare genetic conditions that affect how your cells produce energy. Mitochondria are tiny structures inside nearly every cell in your body that act like power plants, converting food into usable energy through a series of steps called the respiratory chain (also known as the electron transport chain). This chain is made up of several protein complexes (labeled Complex I through V). In these disorders, the body has trouble properly building or putting together one or more of these complexes, which means cells cannot make enough energy to function normally. Because energy production is affected, the organs that need the most energy — such as the brain, muscles, heart, and liver — tend to be hit hardest. Symptoms can vary widely depending on which complex is affected and how severely. Common problems include muscle weakness, developmental delays, seizures, poor growth, heart problems, and vision or hearing loss. Symptoms may appear at birth, during infancy, in childhood, or sometimes later in life. There is currently no cure for these disorders. Treatment focuses on managing symptoms, supporting nutrition, and trying to optimize whatever mitochondrial function remains. Some patients benefit from vitamin and supplement regimens (such as coenzyme Q10, riboflavin, or L-carnitine), though responses vary. Research into gene therapy and other targeted treatments is ongoing, offering hope for the future.

Key symptoms:

Muscle weakness and low muscle toneDevelopmental delays or regression of skillsSeizures or epilepsyPoor growth and failure to thriveExercise intolerance and easy fatigueHeart problems such as cardiomyopathyVision loss or eye movement problemsHearing lossDifficulty breathingLiver dysfunctionLactic acidosis (buildup of acid in the blood)Feeding difficultiesIntellectual disabilityMovement problems such as ataxia or dystoniaStroke-like episodes

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Feb 2026KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Khondrion BV — PHASE3

TrialRECRUITING
Jul 2023Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels

Michio Hirano, MD — PHASE1

TrialRECRUITING
Dec 2022Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

Abliva AB — PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
Phase 31 trial
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Phase 3
Actively Recruiting
· Sites: Boston, Massachusetts; Cleveland, Ohio +8 more · Age: 1899 yrs
Phase 21 trial
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Phase 2
Actively Recruiting
PI: Amel Karaa, MD (Massachusetts General Hospital) · Sites: Akron, Ohio; Houston, Texas +21 more · Age: 1899 yrs
Phase 11 trial
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione Levels
Phase 1
Actively Recruiting
PI: Michio Hirano, MD (Columbia University) · Sites: New York, New York · Age: 1880 yrs

No specialists are currently listed for Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexesForum →

No community posts yet. Be the first to share your experience with Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes.

Start the conversation →

Latest news about Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes

No recent news articles for Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific respiratory chain complex is affected, and has a genetic cause been identified?,What organs should be monitored regularly, and how often do we need follow-up testing?,Are there any medications or supplements that might help, and what is the evidence for them?,What medications or situations should we avoid because they could worsen the condition?,What should we do during an illness or metabolic crisis — do we have an emergency protocol?,Are there any clinical trials or new treatments being studied that we might be eligible for?,What therapies (physical, occupational, speech) would benefit my child or me, and how do we access them?

Common questions about Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes

What is Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes?

Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes is a group of rare genetic conditions that affect how your cells produce energy. Mitochondria are tiny structures inside nearly every cell in your body that act like power plants, converting food into usable energy through a series of steps called the respiratory chain (also known as the electron transport chain). This chain is made up of several protein complexes (labeled Complex I through V). In these disorders, the body has trouble properly building or putting together one or more of these co

Are there clinical trials for Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes?

Yes — 3 recruiting clinical trials are currently listed for Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.